David V. Goeddel is Director & 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM). They have made 65 open-market trades across 5 companies since 2014, most recently 2025-03-05.
CIK 0001182464
65 open-market purchases totalling $270.6M since 2014, never a sale. Across 65 scored buys the stock is up 22.2% at ninety days, and 16.5 points ahead of the S&P over the same stretch.
65 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 57% | 60% | 65% |
| Avg Move | +2.6% | +7.8% | +22.2% |
| Alpha | +2.4% | +7.4% | +16.5% |
| Scored | 65 | 65 | 65 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TNYA | BUY | 2025-03-05 | 2025-03-07 | $0.70 | $50.0M | +31.3% | -9.7% | +1.6% |
| TNYA | BUY | 2024-02-12 | 2024-02-14 | $4.50 | $10.0M | -3.5% | -17.8% | -27.3% |
| NGM | BUY | 2023-11-15 | 2023-11-17 | $0.69 | $18K | +11.5% | +17.8% | +122.4% |
| TNYA | BUY | 2023-03-10 | 2023-03-14 | $2.60 | $18K | -3.4% | +15.3% | +165.3% |
| TNYA | BUY | 2023-02-08 | 2023-02-10 | $2.60 | $3.9M | +5.9% | -1.0% | +154.2% |
| NGM | BUY | 2023-01-30 | 2023-02-01 | $5.00 | $921K | -9.6% | -20.7% | -32.2% |
| NGM | BUY | 2023-01-23 | 2023-01-25 | $5.00 | $50K | +0.4% | -14.4% | -23.3% |
| NGM | BUY | 2023-01-19 | 2023-01-23 | $5.00 | $191K | -0.9% | -12.6% | -25.9% |
| TNYA | BUY | 2023-01-19 | 2023-01-23 | $2.50 | $349K | +10.6% | +7.2% | +98.3% |
| TNYA | BUY | 2023-01-17 | 2023-01-19 | $2.51 | $930K | +20.6% | +12.5% | +26.5% |
| NGM | BUY | 2023-01-12 | 2023-01-17 | $4.95 | $27K | -3.6% | -11.9% | -25.8% |
| NGM | BUY | 2023-01-10 | 2023-01-12 | $4.80 | $2.0M | -7.6% | -9.6% | -33.1% |
| NGM | BUY | 2022-12-12 | 2022-12-14 | $4.98 | $1K | -16.1% | -0.6% | -26.5% |
| NGM | BUY | 2022-11-21 | 2022-11-23 | $5.00 | $202K | +1.5% | -11.7% | -18.3% |
| TNYA | BUY | 2022-11-21 | 2022-11-23 | $2.60 | $50.0M | -13.6% | -30.6% | +20.4% |
| NGM | BUY | 2022-11-03 | 2022-11-07 | $4.92 | $1.4M | -5.7% | -3.3% | -7.1% |
| NGM | BUY | 2022-10-27 | 2022-10-31 | $4.86 | $747K | +3.8% | +0.7% | -8.7% |
| NGM | BUY | 2022-10-25 | 2022-10-27 | $4.81 | $1.2M | +14.1% | +3.4% | +3.6% |
| NGM | BUY | 2022-10-17 | 2022-10-19 | $3.56 | $462K | +36.9% | +40.5% | +33.1% |
| NGM | BUY | 2022-06-09 | 2022-06-13 | $13.50 | $13.7M | +16.0% | +22.4% | +27.6% |
| NGM | BUY | 2022-06-02 | 2022-06-06 | $13.03 | $877K | -7.5% | +2.2% | +6.1% |
| NGM | BUY | 2022-05-31 | 2022-06-02 | $13.46 | $4.1M | -8.8% | +1.7% | +2.5% |
| NGM | BUY | 2022-05-26 | 2022-05-31 | $13.49 | $572K | -8.1% | -8.7% | +5.8% |
| NGM | BUY | 2022-05-24 | 2022-05-26 | $13.41 | $1.6M | +1.1% | +7.8% | +19.5% |
| NGM | BUY | 2022-05-19 | 2022-05-23 | $13.40 | $779K | +5.8% | +0.5% | +19.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.